Oxypoint

Oxypoint nv, a spin-off from the University of Antwerp, develops and commercialises innovative oxygen flow meters for use in hospitals. Their first product is the commercially validated and CE-marked Econo-Comfort TM oxygen flowmeter, which uses Oxypoint’s patented technology.  This combines the operation of a traditional oxygen flow meter with a comfort mode that administers a dose of oxygen only on inhalation. The benefit to the patient – thanks to reduced dehydration of the nasal mucosa – is greatly increased comfort and compliance. Hospitals benefit from reduced waste of medical oxygen and improved oxygen therapy.

Their latest innovation, the Oxypoint O2MATE, records the patient’s breathing. This data is automatically linked to other vital parameters. Smart data analysis allows the medical professional to easily monitor the patient even better via a software platform. The next step after optimising the prototype, is to set up research projects in hospitals that are already actively working with data.

In March 2018, Oxypoint managed to close a Series A financing round. The financing round was led by Flemish investment company PMV, together with a family investor.

With the €3.8 million capital increase, Oxypoint will expand the sales activities of its uniquely patented CE-marked Econo-Comfort™ oxygen flowmeter and finance the development of a new generation of innovative oxygen flowmeters.